NCT05924412View on ClinicalTrials.gov

Parecoxib in Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions
Pain, PostoperativePain, AcuteAnalgesiaAnalgesic NephropathyAnalgesic Adverse ReactionKnee Osteoarthritis
Interventions
DRUG

Intravenous study drug

40mg parecoxib will be administered intravenously after general anesthesia induction and before tourniquet inflation and surgical incisión

OTHER

Intravenous saline solution

Saline solution (same volume as the study drug) will be administered intravenously after general anesthesia induction and before tourniquet inflation and surgical incision

Trial Locations (1)

8380420

Hospital Clinico Universidad de Chile, Santiago

All Listed Sponsors
lead

University of Chile

OTHER